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Micro Exon Gene (MEG) proteins are thought to play major roles in the infection and 
survival of parasitic Schistosoma mansoni worms in host organisms. Here, the physical 
chemical properties of two small MEG proteins found in the genome of S. mansoni, named 
MEG-24 and MEG-27, were examined by a combination of biophysical techniques such as 
differential scanning calorimetry, tensiometry, circular dichroism, fluorescence, and electron 
spin resonance spectroscopies. The proteins are surface active and structurally arranged as 
cationic amphipathic α-helices that can associate with lipid membranes and cause their 
disruption. After adsorption to lipid membranes, MEG-27 strongly affects the fluidity of 
erythrocyte ghost membranes, whereas MEG-24 forms pores in erythrocytes without 
modifying the ghost membrane fluidity. Whole–mount in situ hybridization experiments 
indicates that MEG-27 and MEG-24 transcripts are located in the parasite esophagus and 
tegument, respectively, suggesting a relevant role of these proteins in the host-parasite 
interface. Taken together, these characteristics lead us to propose that these MEG proteins 
may interact with host cell membranes and potentially modulate the immune process using a 
similar mechanism as that described for α-helical membrane active peptides. 
 
Keywords: micron-exon gene proteins, Schistosoma mansoni, circular dichroism 
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1. Introduction  
Schistosomiasis is a widely spread tropical disease caused by organisms of the 
Schistosoma genera, with Schistosoma mansoni as one of the main causative agents, being 
prevalent in tropical regions of Africa and the Americas [1,2]  The analysis of S. mansoni 
genome revealed an intriguing class of genes consisting of small (<36 bp) and symmetric 
exons, which have been designated as Micro Exon Genes (MEGs) [3,4]. These genes encode 
small proteins, ranging from 6 to 20 kDa, which have been suggested to play important roles 
in the host-parasite interface [4]: Their expression is concentrated in intramammalian stages 
and in the esophagus and tegument, which are tissues of the parasite in direct contact with 
host cells.  
The sequences of MEG proteins include predicted signal peptides, suggesting targeting 
to extracellular membranes. Several MEG proteins have been detected by proteomics in 
parasite secretions or tegument surfaces [4], thus confirming their exposure to the host 
membranes. MEGs display an accelerated evolution, with nonsynonymous/synonymous 
substitution rates (dN/dS) higher than most vaccine candidates and an expansion in gene copy 
numbers, indicating an intense evolutionary pressure from the host immune system [5]. The 
fact that MEGs display small symmetrical exons allows for the generation of multiple 
alternatively-spliced transcripts that code for proteins with small changes in their sequences 
[4,5]. This ability appears to be the basis of their mechanism of antigenic variation, which 
allows the detection of multiple proteins with different molecular weights and pIs derived 
from the same gene.  
Orthologs of S. mansoni MEGs have been detected only in other organisms of the 
Schistosoma genera and in the Trichobilharzia regenti [6]. Therefore, the function of MEGs 
cannot be attributed based on homology with proteins with known function or conserved 
domains. Protein structure predictions of MEGs suggest that polipeptides coded by several 
MEG families include a large portion of disordered structure. This was experimentally 
confirmed for MEG-14, which has been classified as an intrinsically disordered protein [7,8]. 
However, several other MEG families have also been predicted to be mainly composed of α-
helix structure with an amphipathic nature [9] 
Evidence of MEG proteins interacting with cells from the immune system has been 
obtained by immunofluorescence microscopy of MEG-4, which showed staining of a halo 
surrounding ingested leukocytes [10] and high concentrations of MEG-4 in the parasite 
esophagus. These results have led to the proposal that the MEG proteins might act as 
important players in blood processing [6,9]. In addition, yeast two-hybrid system, pull down 
and surface plasmon resonance experiments showed that the protein MEG-14 [7] interacts 
with the human S100A9, a protein involved in inflammatory signaling process and highly 
expressed in some cells of the immune system [8] 
In this study, we perform the characterization of two novel small Schistosoma mansoni 
MEG proteins (MEG-24 and MEG-27) that are expressed at different sites in adult worms. 
Both MEGs are arranged in amphipathic helices and interact with membrane models and cell 
membranes, however using different mechanisms. Similar to what is observed for the 
membrane active peptides [11–13], which are naturally-occurring compounds that interact 
with the cell membrane (either passing through it, or inserting at the membrane interface, 
or even causing its disruption), it is believed that specific interactions of these small MEG 
proteins with cell membranes may also disturb the lipid layer physical integrity. 
Great interest has been placed in molecules that act modulating the human immune 
response. The functions related to this modulation include direct chemotactic activity towards 
leukocytes, regulation of TLR-dependent inflammatory responses and promotion of wound 
healing [14,15] 
Despite both proteins displayed membranolytic function on model membranes, only 
MEG-24 has shown pore-forming properties on more complex cell membranes such as those 
from red blood cells. However, MEG-27 also interacts with erythrocyte ghost membranes, 
changing the lipid bilayer fluidity and the melting profiles of the ghost membrane proteins. 
Thus, we hypothesize that MEGs may interact with host cells and putatively influence the 
host immune response system. 
 
2. Experimental section  
2.1. Peptide design and sequence analysis 
As MEG-24 and MEG-27 are both small protein, two polipeptides were designed based 
on the predicted sequence of the mature MEG proteins (signalP program was used to exclude 
the signal peptide), thus MEG-24 (AAVILHPKYEMTFTEKLRFYFRCLVKVLC 
HMIRLGYIGPLSDYYVH) and MEG-27 (IKWVNCSHELNEHTSETSLRRWIHTVFSFL 
FHNF) were custom synthesized by Genscript, EUA. Predictions of secondary structure were 
performed by PSIPRED Server software (http://bioinf.cs.ucl.ac.uk/psipred/). The 
hydrophobicity analysis was performed with the HELIQUEST software 
(http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParamsV2.py). Prediction of transmembrane 
regions was carried out using Phobius [16]  [and TMHMM [17] 
 
2.2. Whole mount in situ hybridization (WISH) 
To assess mRNA expression sites of the MEGs, WISH experiments were performed 
according to a previously described WISH protocol optimized for schistosomes [18]. MEG-24 
and MEG-27 antisense RNAs were used as probes and sense RNA strand as the control.  
 
2.3. Liposome preparation 
Lipid vesicles were prepared with POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine), POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol), POPE 
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), cholesterol, sphingomyelin (N-
octadecanoyl-D-erythrosphingosylphosphorylcholine), and DMPC (1,2-dimyristoyl-sn-
glycero-3-phosphocholine). All lipids were purchased from Avanti Polar Lipids. 
Phospholipids (5 mg/mL) solubilized in chloroform/methanol mixture 4:1 (v/v) were 
deposited in glass tubes and the solvent was slowly evaporated under a continuous nitrogen 
flow, resulting in the formation of a lipid film. An additional drying step was performed using 
a SpeedVac ™ concentrator (SAVANT ™) for at least 4 h. Subsequently, the film was 
resuspended in an appropriate buffer (as specified in each section) for 16 h at 42 oC. The 
resulting multilamellar vesicles were then subjected to 10 cycles of freezing and thawing.  
Small unilamellar vesicles (SUVs) were prepared by submitting the freeze-thawed lipid 
sample to probe tip sonication (5 cycles of 50 seconds) at room temperature. Large 
unilamellar vesicles (LUVs) loaded with 35 mM calcein in water were prepared by submitting 
the freeze-thawed vesicles to an extruder with 0.2 μm polycarbonate membrane to select 
vesicles with standardized radii. After extrusion, the sample was loaded on a Sephadex G-50 
(Sigma Aldrich) 20 cm x 1 cm column to remove the nonencapsulated calcein from the dye-
trapped LUVs. After elution, the liposome concentration was determined using an organic 
phosphorous assay [19] 
 
2.5. Intrinsic tryptophan emission spectrum and calcein leakage (CL) assays 
The emission spectra of the Trp residues of MEG-27 in ultrapure water and in the 
presence of SUVs of POPC (at a 1:100 peptide-to-lipid molar ratio) were measured at 25 oC in 
a K2 Fluorometer (ISS-IL), with a 1-cm pathlength quartz cell and magnetic stirring. The 
sample was excited at 295 nm and the emission spectrum was monitored from 300 to 500 nm. 
The effects of MEG-24 and MEG-27 on membrane permeability were studied by 
measuring the leakage of the fluorescent dye from calcein-entrapped liposomes in 10 mM 
HEPES buffer pH 7.4, 100 mM NaCl. Different peptide-to-lipid molar ratios (1:20, 1:50, 
1:100, 1:250, 1:500, 1:1000 and 1:5000) were used and the kinetics was monitored for 600 
seconds, with the excitation wavelength set to 495 nm and the emission monitored at 520 nm. 
As control of total lysis, liposomes were solubilized with 1% Triton X-100 after each 
measurement. 
 
2.6. Differential scanning calorimetry (DSC)  
LUVs of DMPC in Phosphate-buffered saline were incubated with MEG proteins for 
30 min at 37 oC at diferent lipid-to-peptide molar ratios. DSC measurements were carried out 
using a heating rate of 30 oC/h and a temperature range of 6 to 45 oC. The equilibration period 
was 15 minutes at 6 oC. Erythrocyte ghost membranes were prepared as described in [20]. 
Aliquots were prepared and stored refrigerated until use for up to three days. For reference 
scan, 300 mg/ml of ghost in PBS solution were used. For proteins analisys, 100 mg/ml of 
ghost in PBS solution were incubated with the peptides at 37 °C for 20 min prior to the 
experiments. The peptide concentrations were 1 µM, 5 µM and 15 µM. The heating rate was 
60 oC/h and the temperature range of 15 to 90 oC. The equilibration period was 10 minutes at 
15 oC. All experiments were performed using a microcalorimeter VP-DSC (MicroCal). The 
analysis of thermograms was carried out using MicroCal software, developed within the 
software Origin 7.0. 
 
2.7. Electron spin resonance (ESR) spectroscopy 
ESR experiments were carried out on an X-band E-109 Varian ESR spectrometer 
using the following acquisition parameters: field modulation frequency, 100 kHz; field 
modulation amplitude, 0.5 or 1.0 G; microwave power, 5 mW; and scan width, 100 to 
160 G. Erythrocyte ghost membranes for ESR were prepared as follows: An erythrocyte 
ghost solution was centrifuged at 15,000 × g and the pellet dried at 37 °C for 1 h. The dry 
ghost mass was weighed and divided into 100 mg aliquots, which were resuspended in 1 mL 
of hypotonic buffer (5 mM KCl, 5mM Tris-HCl, pH 7.4) in the presence of 100 µL of 
nitroxide-labeled lipids at 1 mg/mL. The mixture was incubated for 1 hour at 37 ºC. Then, the 
ghosts were centrifuged at 1,500 × g for 1 min and the supernatant was replaced with 1 mL of 
fresh PBS. This washing procedure was repeated 4 times to remove excess spin label. After 
the final wash, the pellet (100 mg) was resuspended in 100 uL of PBS. Three nitroxide lipid 
probes, purchased from Avanti Polar Lipids, Inc. (Alabaster, AL), were used: 1,2-dipalmitoyl-
sn-glycero-3-phospho(tempo)choline (DPPTC), for monitoring the polar region (surface); and 
1-palmitoyl-2-stearoyl(n-doxyl)-sn-glycero-3-phosphocholine (n-PCSL, where n = 5 and 16), 
to monitor the hydrophobic region of the lipid bilayer. POPC/spin labels SUVs samples for 
ESR were prepared as described in section 2.3 with the only modification that both lipid and 
spin labels solubilized in organic solvent were mixed in a glass tube. The samples were 
inserted into capillaries that were sealed and centrifuged prior to the measurements. 
Nonlinear least-squares simulations (NLLS) of the ESR spectra were carried out as 
previously described [21]using the Multicomponent LabView (National Instruments) software 
(http://www.biochemistry.ucla.edu/Faculty/Hubbell/). The components of the g- and 
hyperfine tensors used in the NLLS simulations are shown in Table S1. 
 
2.8. Circular dichroism (CD) spectroscopy 
Conventional CD measurements were performed at 25 °C on a Jasco J-815 spectrometer 
using a quartz cuvette with a 1 mm pathlength. Eight consecutive scans at scanning speed of 
50 nm/min, bandwidth of 1 nm and response of 1s were averaged for each condition over the 
wavelength range of 270 to 195 nm, in 1 nm intervals. MEG-24 or MEG-27 (15 μM) were 
solubilized in water, in the presence or absence of POPC vesicles at different lipid-to-peptide 
molar ratios. The synchrotron radiation circular dichroism (SRCD) spectra of the MEG 
proteins in aqueous solution and in the presene of POPC vesicles were obtained at the AU-CD 
beamline on the ASTRID2 synchrotron (Aarhus University, Denmark). The spectra were 
obtained at 25 ºC with the measurement of 3 scans over the wavelength range from 280 to 170 
nm, with bandwidth of 1 nm and 2 s dwell time, using a demountable quartz Suprasil cuvette 
(Hellma Analytics, UK) with a 0.0097 cm pathlength. All CD/SRCD spectra were processed 
using the CDtool [22] software, which consisted of averaging the scans collected, subtracting 
the respective baseline spectrum, zeroing in the 263–270 nm region, and smoothing with a 
Savitzky–Golay filter. The DichroWeb analysis server [23] was used to calculate the 
secondary structure content using the CDSSTR method and the reference data set SP175 [24] 
The goodness of the fit was evaluated by the calculation of the normalized root mean-square 
deviation (NRMSD) for each analysis [25]  
 Oriented lipid bilayers were prepared with the cosolubilization of POPC and the MEG 
proteins in a mixture of chloroform/methanol 4:1 (v/v) at 1:50 peptide-to-lipid molar ratio, 
followed by the deposition of the mixture onto a circular quartz glass Suprasil plate (Hellma 
Analytics, UK). The plates were dried in a desiccator under vacuum for 3 h to evaporate the 
solvent, and then rehydrated for 16 h in sealed chambers with a saturated solution of K2SO4. 
The oriented CD (OCD) spectra were obtained using a Jasco J-720 CD instrument from 280 
to 190 nm, taking 4 different rotational positions of the plate (0, 90, 180, and 270 degrees), 
which was arranged perpendicular to the light beam. The spectra of the lipids alone were 
subtracted from the final spectrum. 
 
2.9. Surface tension measurements and adsorption on Langmuir monolayers 
The surface activity of MEG-24 and MEG-27 in aqueous solution was assayed in a 
Delta Pi Langmuir-tensiometer (Kibron, Finland) taking measurements for 4 h, at 25oC, with 
MEG-24 and MEG-27 at 10 μM in pure MilliQ water. In addition, small amounts of POPC 
solubilized in methanol/hexane (10/1, v/v, at a 1 mg/mL) were spread on the air/water 
interface of a microplate well filled with 1.2 mL MilliQ water, to generate lipid monolayers 
with lateral packing density of 15, 25 and 35 mN/m. Subsequently, each MEG protein (10 
μM) was injected to the aqueous subphase and the adsorption kinetics of the proteins on 
Langmuir monolayers of POPC were monitored until reaching equilibrium (~2 h). 
 
2.10. Hemolytic assay 
The protocol for blood collection was approved by a research ethics committee from 
Universidade Federal de São Carlos (protocol number 823.540). Informed consent was 
obtained from a healthy volunteer human donor. The collected blood (1 mL) was diluted 10× 
(v/v) in PBS (pH 7.4), then centrifuged at 3500 × g for 10 min at 4 oC to separate the red 
blood cells. Cycles of centrifugation followed by removal of the supernatant were performed 
until the aqueous solution remained clear and colourless after centrifugation. A 1% solution of 
the red cell pellet was then diluted in PBS and aliquoted (100 μL) into 96-well microplates. 
Controls (negative, water, positive, Triton 1% solution) and the MEG proteins at 
concentrations ranging from 0.5 μM to 5 μM were added in duplicate. The plate was 
incubated at 37 °C for 1 h. Hemoglobin was detected in the supernatant at 409 nm in a 
spectrophotometer coupled to a SpectraMaxi3x microplate reader (Molecular Devices).  
 
2.11. Osmotic protection and pore-size estimation  
The method utilized for osmotic protection and pore size estimation was based on a 
previously described protocol [26]. Briefly, PEGs of different radii were used as osmotic 
protectors to determine the average pore size formed in the membrane induced by the 
proteins. The following PEGs of known hydrated diameters were used [26, 27]: PEG 200 (~ 
0.9 nm), PEG 300 (~ 1.2 nm), PEG 400 (~ 1.4 nm), PEG 600 (~ 1.5 nm), PEG 900 (~ 1.7 
nm), PEG 1000 (~ 1.8 nm), PEG 1500 (~ 2.4 nm), PEG 3000 (~ 3.0 nm), and PEG 6000 (~ 5 
nm). 100 μl aliquots of a 1% red blood cell suspension were added to 100 μl of a 30 mM PEG 
solution in PBS, pH 7.4, and then incubated with 80 μM of MEG-24 for 1 h at 37 oC. The 
amount of hemoglobin released in the supernatant was measured in a plate reader at 409 nm 
wavelength. 
 
3. Results  
3.1. Amphipatic helical MEGs are expressed both in the adult worm esophagus and 
tegument  
Bioinformatics studies performed with MEG-24 and MEG-27 sequences reveal that 
both peptides are predicted to have secondary structure mainly composed of α-helical 
elements (Figure S1A). The helical wheel projections of the predicted helices in MEG-24 and 
MEG-27 clearly show their amphipathic character, displaying two opposing hydrophilic and 
hydrophobic faces (Figure S1B). Both sequences exhibit a net positive charge in the 
hydrophilic face of +2 for MEG-27, and +5 for MEG-24, which characterize these proteins as 
cationic amphipathic helices. The distribution of the amino acid residues along the peptides 
primary structure is quite different, though. While MEG-24 displays the apolar and the 
acid/basic residues regularly distributed along the peptide sequence, MEG-27 exhibits a 
polarity gradient, with a more hydrophilic N-terminal segment and a more hydrophobic C-
terminus (Figure S1C). Searches for transmembrane regions in the MEG proteins using 
Phobius and TMHMM indicate that only MEG-24 sequence is predicted to adopt a 
transmembrane topology, most likely between residues 19 and 41, if we only consider 
residues with probability of belonging to a transmembrane domain above 0.1 (Figure S1D). 
The existence of MEGs displaying an amphipathic structure similar to that found in α-
helical membrane-active peptides [27] may suggest a possible analogous function for these 
peptides. Data from RNA-Seq showed an enrichment of MEG-27 transcripts in schistosome 
heads, thus suggesting a focal expression in the esophagus [9]. Such a trend is absent for 
transcripts from MEG-24, suggesting preferential expression of this gene in other tissues. 
Whole-mount in situ hybridization (WISH) experiments were performed using anti-
sense probes, which hybridize to native mRNA strands, from MEG-24 and MEG-27 to 
determine their expression loci in adult worms. The WISH assays revealed that expression of 
MEG-27 is concentrated in the region corresponding to the posterior esophagus of the parasite 
(Figure 1A). The absence of such signal in the negative control using a nucleotide probe 
corresponding to the sense RNA strand provides evidence of specific binding (Figure 1B). In 
contrast, MEG-24 does not exhibit any staining at the parasite esophagus, but displays a 
staining typical of proteins being expressed in subtegumental cells (Figure 1C), while no 
signal is noted in the negative control (Figure 1D).  
 
 
Figure 1. Differential localization of MEGs 24 and 27 in adult worm. (A) WISH using 
MEG-27 antisense probe revealing mRNA expression at the anterior esophagus gland. (B) 
Negative control incubated with MEG-27 sense RNA probe. (C) WISH using MEG-24 
antisense probe showing labeling of subtegumental cells throughout the worm body. (D) 
MEG-24 sense probe, negative control. 
 
3.2. MEG-24 and MEG-27 interact with mimetic membranes  
The results from the WISH experiments support the hypothesis that both MEG-24 and 
MEG-27 act in different regions of the host parasite interface. It might be particularly 
interesting to investigate whether the properties of these proteins are similar to those of 
cationic α-helical membrane-active peptides. Therefore, lipid vesicles were employed to 
evaluate the effect of these peptides on the membrane structural integrity and to investigate 
how lipid environment may modulate the peptide structure. 
MEG-27 and MEG-24 were incubated with POPC vesicles presenting different lipid 
compositions of cholesterol and sphingomyelin. Both proteins were able to promote the 
leakage of calcein from the zwitterionic POPC vesicles, indicating their ability to interact with 
and disturb the packing of this model membrane (Figures 2A and 2B). At relatively high 
concentrations (5 mol% of peptide), approximately 80% leakage was observed for both 
proteins. The presence of either sphingomyelin or cholesterol in the POPC vesicles showed 
little effect on changing the lysis percentage of both MEG proteins, whereas the addition of 
POPG in the vesicle decreased the lytic effect caused by MEG-27 (Figure 2A). However, 
MEG-24 showed a distinct behavior depending on the concentration: below 1 mol%, a 
decreased lysis was also observed, whereas above 2 mol%, MEG-24 promoted higher 
permeabilization of POPG-containing LUVs (Figure 2B). 
 
 
Figure 2. Permeabilization effect of MEG-27 and MEG-24 on lipid model membranes. 
Dose-response leakage data for (A) MEG-27 and (B) MEG-24 acting on POPC, 
POPC/POPG, POPC/Chol, and POPC/SM/Chol LUVs. 
 
Since both MEGs presented high permeabilization activity on zwitterionic POPC 
vesicles, we carried out DSC experiments to better investigate the perturbation caused by the 
MEG proteins on the zwitterionic DMPC. DSC is a very sensitive technique for monitoring 
changes in the phase behavior of lipid membranes induced by external agents such as drugs 
[27], peptides , and proteins [29]. The calorimetric profile of DMPC large unilamellar vesicles 
exhibits two endothermic events related to membrane structural transitions: a less enthalpic 
and less cooperative pretransition at about 12 °C and a more energetic, very cooperative main 
phase transition around 23 °C (black line in Figures 3A and B). The first transition 
corresponds to the formation of the ripple gel phase (Pβ’), whereas the second transition arises 
from the conversion of Pβ’ to the liquid crystalline phase (Lα). Both MEG-27 and MEG-24 
change the thermotropic phase behavior of DMPC in a concentration-dependent manner 
(Figures 3A and B). MEG-27 perturbs both the pretransition and main phase transition more 
significantly than MEG-24. Indeed, the very narrow, cooperative peak at 24.0 oC in the 
protein-free DMPC LUVs becomes very broad in the presence of 2 mol% MEG-27 (linewidth 
increases from 0.6 oC to 8.1 oC), but is marginally affected by MEG-24 (0.87 oC) at the same 
concentration. This result indicates a more effective disruption of lipid-lipid interactions by the 
former MEG protein than by the latter. Furthermore, MEG-27 completely abolishes the DMPC 
pretransition, whereas vesicles with MEG-24 retains the lipid pretransition even at high 
concentrations (2 mol%). This suggests that MEG-27 interacts with DMPC membranes more 
superficially, at the headgroup level [29] whereas MEG-24 inserts into the lipid bilayer and 
does not significantly affect the headgroups. Taken together, our findings suggest different 
mechanisms of membrane disruption and, hence, lytic effect, induced by both MEG proteins. 
Based on effects previously described for antimicrobial peptides in membranes [30] , we 
hypothesize that the interaction of MEG-27 with DMPC disrupts the LUVs and putatively 
forms smaller vesicles, whereas MEG-24 binds to the membranes and possibly inserts among 
the lipid acyl chains, thus marginally perturbing the structural organization of the membrane. 
  
 
Figure 3. Effect of MEG-24 and MEG-27 on zwitterionic PC membranes. (A-B) 
Representative DSC profiles of DMPC LUVs without (black) and with (A) MEG-27 or (B) 
MEG-24 at different peptide-to-lipid molar ratios. The inset illustrates the effect of both 
proteins on the DMPC pretransition. (C) ESR spectra of DPPTC (left), 5-PCSL (center), and 
16-PCSL (right) embedded in POPC SUVs in the absence (black) and presence of 3 mol% of 
MEG-24 (blue) and MEG-27 (red). The representative signals were acquired at 5 oC to 
highlight spectral differences induced by MEGs in the liquid crystalline phase of POPC. The 
arrows point to relevant line shape changes of the ESR spectra due to peptide binding. The 
empirical parameters h+1 and h0 represent the height of the low- and middle-field resonance 
lines and 2Amax corresponds to the out-peak separation of the 5-PCSL spectrum. Scan range: 
120 G for DPPTC and 5-PCSL, and 100 G for 16-PCSL. 
 
Next, we sought to investigate in more details the degree of bilayer perturbation 
induced by both MEGs. To that end, we performed ESR experiments using spin-labeled lipids 
embedded into POPC small unilamellar vesicles to monitor changes on the lipid ordering and 
acyl chain mobility of the lipid bilayers upon addition of 3 mol% of the peptides, which 
correspond to the peptide concentration that promoted the highest lytic effect on a zwitterionic 
PC membrane − about 80% leakage in POPC (Figures 2A and B). ESR spectroscopy along 
with spin labeling has been used to characterize the structural dynamics of both proteins and 
lipids in protein-membrane systems [31,32]. The use of phospholipids with nitroxide probes 
attached to different positions of the lipid acyl chain (5-PCSL and 16-PCSL) and the head 
group region (DPPTC) allowed reporting changes on the hydrophobic core of the membrane 
and at the membrane-water interface, respectively. 
Addition of MEGs to POPC SUVs promotes dramatic changes on the ESR spectra of 
DPPTC, 5-PCSL, and 16-PCSL (Figure 3C). Both peptides profoundly alter the spectral line 
shape, causing line broadening to all signals. The reduction of the ratio of the amplitudes of 
the low- and central-field lines (h+1/h0) of both the DPPTC and 16-PCSL ESR spectra and the 
increase of the outer hyperfine splitting (2Amax) of the 5-PCSL spectrum qualitatively indicate 
an increase of the bilayer packing and/or a decrease of the membrane fluidity by the MEG 
proteins. Nonlinear least squares (NLLS) simulations of the ESR spectra were performed to 
quantitatively determine the contributions from both the rotational diffusion rate (R
┴
), which 
is an indicator of the membrane fluidity, and the order parameter (S0), which is indicative of 
bilayer packing, of the spin-labeled lipids in POPC membranes. 
NLLS spectral fitting (Figure S2) shows that both R
┴
 and S0 are remarkably altered by 
MEG-24 and MEG-27, indicating that both lipid mobility and lateral ordering are perturbed 
(Supplementary Table S2). Indeed, R
┴
 decreased by approximately 30-35% for 5-PCSL and by 
about 9% for 16-PCSL in the presence of the proteins at 5 oC, a temperature at which spectral 
differences are more pronounced. The peptides also promote significant lipid lateral ordering 
of the POPC membrane, increasing the order parameter by 0.06-0.08 for 5-PCSL and by 0.10 
for 16-PCSL at 5 oC (Table S2). This ordering effect has been reported for other membrane-
interacting peptides such as antimicrobial peptides [33,34], cell-penetrating peptides [35], and 
viral fusion peptides [21,36]. Even though both peptides may disrupt membranes through 
different mechanisms, as suggested by DSC, the final peptide/lipid membrane complex, 
formed after membrane disruption and leakage, displays very similar membrane fluidity and 
bilayer packing properties, as seen by ESR. 
Synchrotron radiation circular dichroism (SRCD) spectroscopy was used to investigate 
whether the secondary structures of the peptides were altered by the presence of lipid vesicles. 
The two negative peaks at 222 and 208 nm and the positive peak around 192 nm in the SRCD 
spectrum of MEG-27 in water (Figure 4A) are characteristic of a peptide adopting an α-helix 
conformation, which qualitatively agrees with the structural prediction from the bioinformatics 
analysis. In the presence of POPC vesicles, the intensity of those bands is enhanced. As the 
POPC-to-MEG-27 molar ratio increased, so did the peak intensities at 192 and 222 nm (Figure 
4A), suggesting that the partition of the peptide into the POPC vesicles results in a higher helix 
content of MEG-27. Secondary structure content estimation from SRCD spectra confirmed 
that the percentage of α-helix increased from 33% in the apo form to 59% in the presence of 
POPC vesicles at a 200:1 lipid-to-peptide molar ratio, whereas the unordered structure 
decreased from 34% to 27% (Table 1). Disorder-to-order transitions in the presence of lipids is 
a common trend in membrane-active peptides [37,38].  
The SRCD spectrum of MEG 24 is characteristic of a peptide rich in helical structures 
and its devonvolution showed 61% of helix content (Figure S3). The CD spectra of MEG-24 
in the presence of the zwitterionic vesicles, however, are virtually the same as the spectrum 
acquired in solution, maintaining the lineshape characteristic of an α-helix-rich structure 
under both conditions (Figure 4B).  
 
 
Figure 4. Circular dischroism spectra of MEG-27 and MEG-24 in POPC vesicles. (A) 
SRCD spectra of MEG-27 in water and in the presence of POPC vesicles at different lipid-to-
peptide molar ratios (L/P). (B) CD spectra of MEG-24 in water and in the presence of POPC 
vesicles at different L/P. 
 
Table 1: Deconvolution of SRCD spectra of MEG-27 in the apo form and in the presence of 
POPC vesicles at different lipid-to-peptide molar ratios.  
 % helix % sheet % turns % unordered NRMSD* 
Apo 33 18 15 34 0.033 
50:1 37 17 13 33 0.033 
100:1 41 16 12 31 0.026 
200:1 59 12 11 27 0.024 
*NRMSD < 0.1 suggests the calculated spectra fit well to the experimental data. 
 
MEG-27 has two tryptophan residues in its sequence; one of them is located within the 
hydrophobic face of the amphipathic helix (Figure S1), thus making it an excellent probe for 
interaction with membranes using intrinsic fluorescence measurements. When this peptide is 
incubated with POPC vesicles, a substantial blueshift from ~ 350 nm to ~ 330 nm is observed 
(Figure S4). Such a blueshift is characteristic of a decrease in solvent exposure and therefore 
indicates that one or both tryptophans are interacting with the vesicles [39,40]. MEG-24, on 
the other hand, does not have any Trp residues in its sequence to be monitored by fluorescence 
spectroscopy.  
In aqueous solution, both peptides were able to migrate from the subphase to the 
water-air interface (Fig. 5A), presenting moderate surface activity throughout the time 
measured, causing surface pressure changes of 15 and 25 mN/m, respectively. MEG-27 
presented higher surface activity compared to that of MEG-24, in agreement with the higher 
disturbing effect of MEG-27 in model membranes, previously seen by DSC. In addition, both 
MEG-24 and MEG-27 were able to adsorb onto the surface of POPC monolayers (Fig. 5B). 
The changes monitored in lateral pressure over time are due to the occurring peptide-lipid 
interactions at the monolayer surface. However, as the initial POPC lateral pressure was 
increased from 15 to 25 mN/m, the changes in lateral pressure were significantly reduced. 
Only a minor adsorption of MEG-27 onto the POPC monolayer with initial surface pressure 
of 35 mN/m was observed (surface pressure changes of ~4 mN/m). However, at this 
condition, no changes in lateral pressure have been detectec for the interaction with MEG-24. 
The maximum insertion pressures (MIP) of MEG-24 in POPC monolayers was 
determined et ca. ~37 mN/m, suggesting its ability to disturb zwitterionic lipid systems, but 
preferably more fluid lipid system. Whereas for MEG-27, a MIP of ~43 mN/m was measured, 
which is well above the lateral pressure estimated for a biological membrane (30–35 mM/m) 




Figure 5. Surface properties of MEG-24 and MEG-27. (A) Surface activity of MEG-24 
(red) and MEG-27 (blue) on an air–water interface. Black curve shows the surface pressure of 
an aqueous solution (control) throughout the assay. (B) Adsorption of MEGs (10 μM) onto 
POPC monolayers formed at the air–water interface under different initial surface pressures 
(π0). Surface pressure changes (Δπ) induced by peptide adsorption onto POPC monolayer 
were monitored. 
 
3.3. MEG-24 is a pore-forming amphipathic helix  
The helicoidal region of MEG-24 is predicted to have properties common to trans-
spanning helices (Figure S1D) and the presence of a hydrophilic face in that helix suggests a 
pore-forming property for this peptide. To verify whether that was the case, the hemolytic 
activity of MEG-24 was tested. At a fixed concentration of 15 µM, about 20% of erythrocyte 
hemolysis occurred after one hour and a linear increase in hemolysis over time was observed, 
reaching 60% after 6 h of incubation (Figure 6A). From the concentration dependent 
experiment, a HC50 of approximately 40 µM was verified with 1 h incubation (Figure 6B), 
being considered a weakly hemolytic peptide [42] when compared to known efficient 
hemolytic peptides [43,44] It has been shown that incubating erythrocytes with polyethylene 
glycol (PEG) of different sizes allows efficient blockage of the pores induced by pore-forming 
peptides [45] . The effect of different PEGs on the hemolysis promoted by MEG-24 was tested 
and those exhibiting hydrodynamic diameters of at least 3 nm, such as PEG-3000, completely 
inhibited hemolysis (Figures 6C and 6D). This result indicates that the pores formed by MEG-
24 display a cavity size of less than 3 nm. A similar pore size has been suggested for 
antimicrobial peptides like melittin [46] and defensins [43]. MEG-27 did not display hemolytic 
activity under the same conditions (data not shown).  
In addition, the oriented CD spectrum of MEG-24 in planar POPC lipid bilayers shows 
a signal characteristic of a peptide inserted at a tilted angle (I-state) relative to the membrane 
surface (Figure S5), thus providing further evidence of a transmembrane topology [47] 
 
 
 Figure 6. MEG-24 shows hemolytic activity.  Hemolysis promoted by MEG-24 was 
monitored with increasing concentration of the peptide (A) or at a fixed concentration (15 
µM) with increasing time (B). (C) Hemolysis inhibition assay in the presence of PEGs of 
varied sizes. (D) Hemolysis and PEG inhibition assays as visualized in a 96-well plate (U 
bottom). Row I: erythrocytes in the presence of MEG-24 (80 µM) and different sized PEGs 
(0.9 − 5 nm). Row II: erythrocytes in the presence of PEGs only. Row III: supernatant of row 
I to better visualize the hemoglobin release. The last row shows the erythrocytes incubated 
with MEG-24 (80 µM) or TritonX-100 as the positive control of lysis. 
 
3.4. MEG-24 and MEG-27 change the properties of cell membranes  
To better understand the dynamics of the interaction of MEG-27 and MEG-24 with 
components of cellular membranes, DSC assays were performed on erythrocyte ghosts. The 
thermogram of the ghost erythrocyte membrane shows a very complex profile, in which four 
protein transitions can be observed (Figure 7A). The first peak, called transition I, refers to a 
domain formed by spectrin complexes; transition II corresponds to the denaturation of a 
domain formed by glycophorins and several proteins such as band 2.1, 4.1 and 4.2; the peak 
ascribed to III corresponds to the transition of the transmembrane protein domain of band 3, 
and finally, transition IV has no clear description in the literature, being known only that they 
are due to proteins in the membrane [44]. 
The interaction of MEG-27 or MEG-24 with ghost erythrocyte membranes 
considerably alters the melting temperature of band 3 and changes the relative enthalpy, ΔH, 
between all transitions in a concentration-dependent manner (Figure 7A and 7B). The 
importance of band 3 protein has been ascribed to interactions with pathogens [48], 
hemoglobin [49], and the liberation of sphingosine 1-phosphate, which is associated with 
lymphocyte attraction [50], metabolic tissue sensor and a role in chloride shift [51] Therefore, 
changes in the band 3 protein may indicate an interesting mechanism for interaction, given the 
importance of this protein in several vital cellular processes. Interestingly, MEG-24 induced 
the formation of an additional peak at about 20 °C in the calorimetric profile of the ghost 
erythrocyte membrane in a concentration-dependent manner (Figure 7B). This transition 
vanishes upon denaturation of the erythrocyte ghost proteins, ruling out the possibility of being 
ascribed to particular lipid domains/structures induced by MEG-24. Therefore, this peak likely 
stems from the interaction between MEG-24 and ghost membrane proteins, but the real source 
is still unclear. 
To gain further insights into the effects of the MEG proteins on the structural 
organization of the erythrocytes membranes, we performed ESR experiments using the spin-
labeled lipids DPPTC, 5-PCSL, and 16-PCSL embedded into ghost erythrocyte membranes to 
monitor changes on the lipid ordering and mobility of distinct regions of the membranes. 
Figures 7C and 7D illustrate representative ESR spectra of DPPTC, 5-PCSL, and 16-
PCSL in erythrocyte ghost membranes at 37 oC in the absence and presence of 15 μM of 
MEG-27 (Figure 7C) and MEG-24 (Figure 7D). No alteration in the ESR lineshape was 
observed in the presence of 15 μM of MEG-24, a concentration that is known to promote 30% 
hemolysis of erythrocytes (Figure 5A) and to cause significant changes in the melting profile 
of the ghost erythrocyte proteins (Figure 7B). This result suggests that the bulk lipids of the 
erythrocyte ghost membranes are not affected by MEG-24 binding. 
 
 
Figure 7. Effect of MEG-27 and MEG-24 on erythrocytes ghosts. (A-B) DSC thermograms 
of erythrocyte ghosts in the absence (black) and in the presence of (A) MEG-27 and (B) MEG-
24 at different concentrations. (C-D) ESR spectra of DPPTC, 5-PCSL, and 16-PCSL 
embedded in the erythrocyte ghost membranes in the absence (black) and in the presence (red) 
of 15 μM of (C) MEG-27 and (D) MEG-24. Spectra were acquired at 37 oC. 
  
On the other hand, addition of MEG-27 alters the ESR line shape of all lipid probes, 
suggesting that this peptide has a large impact on membrane structure and dynamics that 
extends from the lipid/water interface down to the bilayer center. MEG-27 caused line 
narrowing of all spectra in a concentration-dependent manner (Figure S6). NLLS spectral 
simulations suggest that both the mobility, R
┴
, and the ordering, S0, of the spin-labeled lipids in 
the erythrocyte ghost membranes are significantly changed by the presence of MEG-27 
(Figure S6 and Table S2). Indeed, R
┴
 increased by 58% (from 4.1 to 6.5 × 107 s-1) for DPPTC, 
37% (from 4.6 to 6.3 × 107 s-1) for 5-PCSL, and 69% (2.3 to 3.9 ×108 s-1) for 16-PCSL, 
whereas S0 decreased by 0.25 for DPPTC, 0.09 for 5-PCSL, and 0.08 for 16-PCSL. These 
results show that MEG-27 promoted a pronounced fluidizing effect of the ghost erythrocyte 
membranes at high concentration (15 μM). 
  
4. Discussion  
The difficulty in assigning functions to MEG proteins derives from the lack of 
orthologs with described function. Moreover, MEGs were classified into families based on 
sequence homology, with no sequence similarity between members of different MEG families. 
However, most proteins coded by MEGs display very low molecular weight (< 10 kDa) and 
predictions of their secondary structures may offer hints as to their behaviors. An example of 
such approach was described for MEG-14, where bioinformatics analyses predicted an 
intrinsically disordered protein, which was later experimentally confirmed [7]  and led to 
identification of a human interaction partner [8]. In the present work, two MEGs composed 
mostly of a cationic amphipathic helix displayed features similar to those described for α-
helical membrane-active peptides, leading to their proposed interaction with biological 
membranes.  
The MEGs coding for peptides with amphipathic helices clearly showed a tendency to 
interact with biological membranes. Both peptides interact with membrane mimetics leading to 
the leakage of entrapped calcein into vesicles. Moreover, peptide-lipid interactions promote an 
increase in MEG-27 α-helical content and alter the properties of DMPC vesicles and 
erythrocytes ghosts, as assessed by DSC. Thus, we hypothesize that both MEG-24 and MEG-
27 might play a role in the cell membranes or vesicular structures in the parasite.  
Further analyses suggest that the dynamics of interaction of MEG-24 and MEG-27 with 
membranes are different. The hemolytic activity of MEG-24 and its inhibition by PEGs of 
specific sizes suggest that MEG-24 might act as a pore-forming peptide in complex cell 
membranes, such as red blood cells. MEG-24 also displays a small effect on the cooperativity 
of the melting transition and a marginal perturbation on the lipid headgroup, as seen by DSC. 
These results are consistent with the finding that MEG-24 acquires a tilted transmembrane 
topology, as shown by oriented CD. It has been shown that peptides displaying an amphipathic 
α-helix exhibit cell-penetrating properties, with formation of pores as a possible mechanism of 
their internalization [52] into mammalian cells. The low hemolytic activity by MEG-24 and its 
expression in the parasite tegument rather than in the esophagus, makes it unlikely that the role 
of MEG-24 is to promote hemolysis in a biological context.  
MEG-27, however, affect lipid transitions and disturb lipid membranes more 
effectively than MEG-24. MEG-27 significantly perturbs the cooperativity of DMPC melting 
transition along with the pretransition, which is sensitive to changes in the headgroup 
structure. Even though MEG-27 does not promote hemolysis, it does perturb both proteins and 
lipids of ghost erythrocyte membranes. These results might suggest that MEG-27 causes 
membrane disruption by preferentially binding to the membrane surface. Particularly, a 
membrane surface adsorption could explain the remarkable changes of the ghost erythrocyte 
membrane fluidity measured by ESR. This contrasts with ESR results for the membrane-
spanning MEG-24, where no change on the lipid fluidity and bilayer packing of the ghost 
membrane was observed. The lack of ESR spectral changes remains unclear to us, but it is 
tempting to speculate on that. The highest peptide concentration used in the ESR experiments 
with the ghosts is such that caused only 30% hemolysis of erythrocytes. Thus, at that 
concentration, pore formation takes place with cavity size of up-to 3-nm diameter. 
Furthermore, the appearance of an additional peak on the DSC thermogram of the ghost 
erythrocyte/MEG-24 system in a concentration-dependent manner suggests the formation of a 
protein/peptide complex. MEG-24 does interact with ghost erythrocyte proteins and 
membrane. Therefore, the formation of local structures, such as pores or an erythrocyte 
protein/MEG-24 complex, are expected to have a reduced impact in the bulk lipids and may 
explain the lack of ESR spectral changes. We also do not discard the possibility of a 
cooperative effect of MEG-24 on the ghost erythrocyte membranes. 
The findings observed for MEG-24 and MEG-27 in this study suggest that they are 
able to interact with both model and cell membranes through different mechanisms and can 
affect both lipid and proteins in more complex biological membranes in a manner simliar to 
that observed for several membrane-active peptides. It has been proposed that some 
membrane active peptides can play important roles in mammalian immune system [15, 49]. In 
fact, the analysis of the secretory proteome of the helminth Fasciola hepatica identified a 8 
kDa protein with immune-modulatory properties which presented several features coincidental 
to MEG-24 and MEG-27, including the presence of a secretory signal peptide, prediction of 
an amphipathic helix and lack of conserved domain that could infer any known function 
[53,54]. Moreover, the cationic α-helical peptide LL-37 has been shown to be involved in 
modulation of inflammatory responses [55]. The interaction of MEG-14 with a human protein 
responsible for regulation of inflammatory responses has also been described [8]. Therefore, it 
is tempting to suggest that MEG-24 and MEG-27 may also interact with the host immune 
system, although experimental evidence is still lacking, which is a promising future direction 
in working with this intriguing class of MEG peptides with yet unknow function. 
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